Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $5.48B | +$231M | 87 | 0.15% | Increased |
|
| 2 |
BlackRock
New York
| $5.41B | +$133M | 93 | 0.17% | Increased |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $2.91B | +$201M | 64 | 0.29% | Increased |
|
| 4 |
State Street
Boston,
Massachusetts
| $2.85B | +$257M | 90 | 0.17% | Increased |
|
| 5 |
Janus Henderson Group
London,
| $1.89B | +$64.8M | 27 | 1.35% | Increased |
|
| 6 |
Dodge & Cox
San Francisco,
California
| $1.88B | -$25M | 1 | 1.29% | Reduced |
|
| 7 |
Wellington Management Group
Boston,
Massachusetts
| $1.7B | +$65.4M | 20 | 0.34% | Increased |
|
| 8 |
Primecap Management
Pasadena,
California
| $1.66B | -$24.7M | 5 | 1.52% | Reduced |
|
| 9 |
T. Rowe Price Associates
Baltimore,
Maryland
| $1.35B | +$60.2M | 45 | 0.22% | Increased |
|
| 10 |
Morgan Stanley
New York
| $1.31B | +$174M | 101 | 0.15% | Increased |
|
| 11 |
Franklin Resources
San Mateo,
California
| $1.14B | -$211M | 25 | 0.59% | Reduced |
|
| 12 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $1.13B | -$357M | 7 | 2.27% | Reduced |
|
| 13 |
Geode Capital Management
Boston,
Massachusetts
| $1.09B | +$68.4M | 103 | 0.15% | Increased |
|
| 14 |
Bank of America
Charlotte,
North Carolina
| $1.01B | -$51.3M | 95 | 0.11% | Reduced |
|
| 15 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $955M | -$155M | 8 | 0.73% | Reduced |
|
| 16 |
RTW Investments
New York
| $936M | +$17.5M | 9 | 19.1% | Increased |
|
| 17 |
Charles Schwab
San Francisco,
California
| $831M | +$32.6M | 54 | 0.27% | Increased |
|
| 18 |
Capital World Investors
Los Angeles,
California
| $810M | +$78.7M | 7 | 0.17% | Increased |
|
| 19 |
JP Morgan Chase
New York
| $761M | -$120M | 77 | 0.1% | Reduced |
|
| 20 |
Goldman Sachs
New York
| $749M | -$76.9M | 67 | 0.18% | Reduced |
|
| 21 |
Northern Trust
Chicago,
Illinois
| $725M | +$7.35M | 82 | 0.15% | Increased |
|
| 22 |
ARK Investment Management
St. Petersburg,
Florida
| $723M | -$143M | 5 | 6.26% | Reduced |
|
| 23 |
EC
EcoR1 Capital
San Francisco,
California
| $707M | +$74.7M | 13 | 21.51% | Increased |
|
| 24 |
Avoro Capital Advisors
New York
| $702M | +$28.2M | 4 | 10.5% | Increased |
|
| 25 |
Bank of New York Mellon
New York
| $657M | +$1.88M | 63 | 0.15% | Increased |
|